Breeda O'Donoghue, a 66-year-old woman, died from total organ failure after using the weight-loss drug Ozempic. Her family is raising awareness about the drug's potential side effects, prompting a Cork coroner to notify the Health Products Regulatory Authority. Assistant State Pathologist Dr. Margaret Bolster acknowledges the complexity of the case and expresses frustration in finding a lab capable of testing Ozempic levels in blood samples, underscoring concerns about monitoring drug safety and efficacy. The family's tragedy calls for more rigorous guidelines on the use of Ozempic and similar medications.
The circumstances of the death of mother and grandmother Breeda O'Donoghue are now under investigation, with the family urging greater awareness of Ozempic's potential dangers.
This is a very complex case that is multifactorial, says Assistant State Pathologist Dr. Margaret Bolster, emphasizing the challenges of establishing a direct link.
Dr. Bolster noted ongoing difficulties in testing for Ozempic levels in blood, raising concerns over monitoring and knowledge of its side-effects.
With the family's tragic experience, there’s a growing call for clearer guidelines on the usage and monitoring of Ozempic for weight loss.
Collection
[
|
...
]